The mean dissolution time depends on the dose/solubility ratio

Pharmaceutical Research

Volumn 20, Issue 3, 2003, Pages 406-408

  Rinaki, Eleni ^a   Dokoumetzidis, Aristides ^a   Macheras, Panos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Dissolution; Dose solubility ratio; Mean dissolution time; Solubility

Indexed keywords

DIGOXIN; GRISEOFULVIN; METOPROLOL; PANADIPLON;

ARTICLE; DRUG ABSORPTION; DRUG DOSE; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; LITERATURE; PRIORITY JOURNAL; SIMULATION;

ALGORITHMS; DOSE-RESPONSE RELATIONSHIP, DRUG; METOPROLOL; MODELS, BIOLOGICAL; PHARMACOKINETICS; SOLUBILITY; TABLETS;

EID: 0037335193     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022652004114     Document Type: Article

References (15)

1. K. Yamaoka, T. Nakagawa, and T. Uno. Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6:547-558 (1978).
2. D. Brockmeier. Mean time concept and component analysis in pharmacokinetics. Int. J. Clin. Pharmacol. Ther. 37:555-561 (1999).
3. D. Brockmeier, D. Voegele, and H.M von Hattinberg. In vitro-in vivo correlation, a time sampling problem. Arzneim. Forsch. Drug Res. 33:598-601 (1983).
4. P. Lansky and M. Weiss. Does the dose-solubility ratio affect the mean dissolution time of drugs? Pharm. Res. 16:1470-1476 (1999).
5. A. S. Noyes and W. R. Whitney. The rate of solution of solid substances in their own solutions. J. Amer. Chem. Soc. 19:930-934 (1897).
6. Y. Tanagawara, K. Yamaoka, T. Nakagawa, and T. Uno. New method for the evaluation of in vitro dissolution time and disintegration time. Chem. Pharm. Bul. 30:1088-1090 (1982).
7. R. K. Brazzell and S. A. Kaplan. Factors affecting the accuracy of estimated mean absorption times and mean dissolution times. J. Pharm. Sci. 72:713-715 (1983).
8. max for detecting differences in in vivo dissolution rates. J. Pharm. Sci. 74:1340-1342 (1985).
9. N. D. Eddington, P. Marroum, R. Uppoor, A. Hussain, and L. Augsburger. Development and internal validation of an in vitro- in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation. Pharm. Res. 15:466-473 (1998) Erratum. Pharm. Res. 15:1320 (1998).
10. L. X. Yu and J. R. Crison. and G.L Amidon. Compartmental transit and dispersion model analysis for small intestinal transit flow in humans. Int. J. Pharm. 140:111-118 (1996).
11. L. X. Yu. An integrated model for determining causes of poor oral drug absorption. Pharm. Res. 16:1883-1887 (1999).
12. J. B. Dressman and D. Fleisher. Mixing-tank model for predicting dissolution rate control of oral absorption. J. Pharm. Sci. 75:109-116 (1986).
13. G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413-420 (1995).
14. L. X. Yu, G. L. Amidon, J. E. Polli, H. Zhao, M. U. Mehta, D. P. Conner, V. P. Shah, L. J. Lesko, M. L. Chen, V. H. Lee, and A. S. Hussain. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res. 19:921-925 (2002).
15. L. X. Yu, E. Lipka, and G. L. Amidon. Transport approaches to the biopharmaceutical design of oral drug delivery systems. Adv. Drug Deliv. Rev. 19:359-376 (1996).